Spinal Cord Stimulation Assisted by Motor Rehabilitation Training for Restoring Motor Function After Spinal Cord Injury
Launched by IRCCS SAN RAFFAELE · Jun 23, 2023
Trial Information
Current as of May 04, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating the effects of spinal cord stimulation (SCS) combined with motor rehabilitation training to help improve movement in people who have suffered spinal cord injuries. The research will enroll ten participants, aged 18 and older, who have been diagnosed with spinal cord injuries for at least a year and experience difficulty standing or walking. Participants must also be recommended for SCS surgery due to chronic pain and must not be taking certain medications that could interfere with the study.
During the trial, participants will receive spinal cord stimulation alongside daily locomotor training, which aims to help them regain the ability to stand and step independently. The goal is to see if this combined approach can significantly improve their motor function. If you or someone you know is interested in participating, it's essential to consider the eligibility criteria and be prepared to attend scheduled visits throughout the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of SCI from at least one-year post injury;
- • Complete or incomplete spinal cord damage (ASIA grade A, B or C) conditioning chronic neuropathic pain and motor impairment
- • Age \> 18 years;
- • Indication to spinal cord stimulation surgery for chronic pain;
- • Be unable to stand or step independently;
- • No current anti-spasticity medication regimen;
- • No botox injections in the prior 3 months;
- • Evidence of a personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study;
- • Willingness and ability to comply with scheduled visits and other trial procedures.
- Exclusion Criteria:
- • Any person unable to lie still within the environment of the MRI scanner for the required period to perform the study and those where MRI scanning is contraindicated (i.e. metal clips, claustrophobia);
- • Pregnancy or breastfeeding;
- • Any significant psychiatric disease;
- • Use of illicit drugs;
- • Unstable medical condition without cardiopulmonary disease or dysautonomia that would contraindicate standing or stepping;
- • Painful musculoskeletal dysfunction, unhealed fracture, contracture, pressure sore, or urinary tract infection that might interfere with stand or step training;
About Irccs San Raffaele
IRCCS San Raffaele is a prestigious research hospital and clinical trial sponsor based in Milan, Italy, renowned for its commitment to advancing medical science through innovative research and high-quality patient care. As an Institute for Research and Healthcare, it specializes in a wide range of therapeutic areas, including oncology, neurology, and cardiology, and is dedicated to translating scientific discoveries into effective clinical practices. With a multidisciplinary team of experts and state-of-the-art facilities, IRCCS San Raffaele plays a pivotal role in conducting rigorous clinical trials that contribute to the development of novel treatments and improve patient outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Milan, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported